AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moorman, P. G.
Right arrow Articles by Newman, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moorman, P. G.
Right arrow Articles by Newman, B.
Related Collections
Right arrow Cancer
Right arrow Women's Health

American Journal of Public Health, Vol 90, Issue 6 966-971, Copyright © 2000 by American Public Health Association

JOURNAL ARTICLE

Menopausal hormones and breast cancer in a biracial population

PG Moorman, H Kuwabara, RC Millikan and B Newman
Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Conn., USA. patricia.moorman@yale.edu

OBJECTIVES: This study examined the association between menopausal hormones and breast cancer in a biracial population. METHODS: Logistic regression was used to calculate odds ratios for breast cancer associated with hormone use among 397 cases and 425 controls, all menopausal women. RESULTS: Odds ratios for ever use of hormones were 0.8 (95% confidence interval [CI] = 0.5, 1.2) for White women and 0.7 (95% CI = 0.4, 1.2) for Black women. Risk was not increased with longer duration of use or more recent use. CONCLUSIONS: Breast cancer risk was not increased among White or Black women who used menopausal hormones, despite patterns of use varying considerably between races.


This article has been cited by other articles:


Home page
 Hum Reprod UpdateHome page
C. M. Greiser, E. M. Greiser, and M. Doren
Menopausal hormone therapy and risk of breast cancer: a meta-analysis of epidemiological studies and randomized controlled trials
Hum. Reprod. Update, November 1, 2005; 11(6): 561 - 573.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. P. Pinheiro, M. D. Holmes, M. N. Pollak, R. L. Barbieri, and S. E. Hankinson
Racial Differences in Premenopausal Endogenous Hormones
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2147 - 2153.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
P. A. Newcomb, L. Titus-Ernstoff, K. M. Egan, A. Trentham-Dietz, J. A. Baron, B. E. Storer, W. C. Willett, and M. J. Stampfer
Postmenopausal Estrogen and Progestin Use in Relation to Breast Cancer Risk
Cancer Epidemiol. Biomarkers Prev., July 1, 2002; 11(7): 593 - 600.
[Abstract] [Full Text] [PDF]

Home page
 Journal of the American Dental AssociationHome page
A. H. FRIEDLANDER
The physiology, medical management and oral implications of menopause
J Am Dent Assoc, January 1, 2002; 133(1): 73 - 81.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Public Health Association